Partner at White & Case LLP
Raj Gandesha is a partner in White & Case’s Global Intellectual property practice and represents US and international clients in high-stakes IP, antitrust and commercial litigation matters, with a special focus on litigations that raise novel issues, at the intersection of patent law, innovation policy and competition law.
Mr Gandesha’s recent matters include the following:
- Defending Pfizer in multiple nationwide class action antitrust and RICO litigations with respect to EpiPen, Lipitor, Effexor XR, Humira and Celebrex accusing the company of delaying entry of generic competition through, among other things, alleged “reverse payment” patent settlements, “sham” FDA citizen petitions, “sham” patent litigation, fraud on the FDA, purported “product hopping” and fraud on the USPTO;
- Representing a European innovator of speech recognition technology in US patent litigation commenced by an incumbent US competitor in which the former asserts antitrust and unfair competition counterclaims against the latter based on patent thicketing, sham patent litigation and other competition-foreclosing conduct;
- Representing a generic drug manufacturer in multiple state and federal actions alleging False Claims Act, common law fraud and consumer protection claims based on allegations that drug manufacturers reported inaccurate pricing benchmarks, which allegedly caused state Medicaid agencies to overpay for prescription drugs provided to Medicaid beneficiaries;
- Securing on behalf of a major national oil company the complete dismissal at the motion to dismiss stage, under, among other things, the political question and act of state doctrines, of a putative class action alleging price fixing of refined petroleum products relating to OPEC;
- Representing a major pharmaceutical manufacturer in a novel trade secret misappropriation matter before the US International Trade Commission concerning alleged theft of bacterial strains that resulted in a successful settlement for our client;
- Securing on behalf of landline and wireless telephone companies the complete dismissal of multi-party federal patent infringement actions concerning international call-blocking technology; and
- Representing a performing rights society in litigation concerning novel copyright issues relating to the transmission of music on the Internet.